1
/
of
1
ELK Biotechnology
SKU:ELK8833
General ACTb(Actin Beta) ELISA Kit
General ACTb(Actin Beta) ELISA Kit
Regular price
$458.00 USD
Regular price
Sale price
$458.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
General ACTb(Actin Beta) ELISA Kit
Overview
| Product name: | General ACTb(Actin Beta) ELISA Kit |
| Reactivity: | General |
| Alternative Names: | ACT-B; PS1TP5BP1; Actin, cytoplasmic 1; Actin, cytoplasmic 1, N-terminally processed |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 0.057 ng/mL |
| Standard: | 10 ng/mL |
| Detection Range: | 0.16-10 ng/mL |
| Sample Type: | tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Assay Length: | 2h |
| Research Area: | Signal transduction;Developmental science;Bone metabolism; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with ACTb protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to ACTb. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of ACTb in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 10.00 | 0.237 | — |
| 5.00 | 0.370 | — |
| 2.50 | 0.577 | — |
| 1.25 | 0.899 | — |
| 0.63 | 1.253 | — |
| 0.32 | 1.579 | — |
| 0.16 | 1.889 | — |
| 0.00 | 2.325 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant ACTb and the recovery rates were calculated by comparing the measured value to the expected amount of ACTb in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 83-97% | 90% |
| EDTA plasma(n=5) | 81-95% | 88% |
| Heparin plasma(n=5) | 85-95% | 92% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of ACTb and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 82-103% | 81-91% | 92-102% | 81-90% |
| EDTA plasma(n=5) | 89-105% | 87-98% | 92-100% | 88-104% |
| Heparin plasma(n=5) | 87-93% | 93-105% | 85-99% | 90-99% |
Share
